Information Journal Paper
APA:
CopyMORENO, S., MIRALLES, P., DIAZ, M.D., BARAIA, J., PADILLA, B., & BERENGUER, J.. (1997). ISONIAZID PREVENTIVE THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PERSONS LONG–TERM EFFECT ON DEVELOPMENT OF TUBERCULOSIS AND SURVIVAL. ARCHIVES OF INTERNAL MEDICINE, 157(15), 1729-1734. SID. https://sid.ir/paper/531679/en
Vancouver:
CopyMORENO S., MIRALLES P., DIAZ M.D., BARAIA J., PADILLA B., BERENGUER J.. ISONIAZID PREVENTIVE THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PERSONS LONG–TERM EFFECT ON DEVELOPMENT OF TUBERCULOSIS AND SURVIVAL. ARCHIVES OF INTERNAL MEDICINE[Internet]. 1997;157(15):1729-1734. Available from: https://sid.ir/paper/531679/en
IEEE:
CopyS. MORENO, P. MIRALLES, M.D. DIAZ, J. BARAIA, B. PADILLA, and J. BERENGUER, “ISONIAZID PREVENTIVE THERAPY IN HUMAN IMMUNODEFICIENCY VIRUS INFECTED PERSONS LONG–TERM EFFECT ON DEVELOPMENT OF TUBERCULOSIS AND SURVIVAL,” ARCHIVES OF INTERNAL MEDICINE, vol. 157, no. 15, pp. 1729–1734, 1997, [Online]. Available: https://sid.ir/paper/531679/en